Breast cancer cells regulate angiogenesis by secreting various pro‐angiogenic factors such as vascular endothelial growth factors (VEGF), basic fibroblast growth factors (FGF2), interleukins, platelet‐derived growth factor (PDGF), transforming growth factors β (TGFβ), and tumor necrosis factors (TNF) [2, 3]. The gene discussed is FGF2; the disease is breast carcinoma.